Astaxanthin from Crustaceans and Their Byproducts: A Bioactive Metabolite Candidate for Therapeutic Application

Mar Drugs. 2022 Mar 12;20(3):206. doi: 10.3390/md20030206.

Abstract

In recent years, the food, pharma, and cosmetic industries have shown considerable interest in bioactive molecules of marine origin that show high potential for application as nutraceuticals and therapeutic agents. Astaxanthin, a lipid-soluble and orange-reddish-colored carotenoid pigment, is one of the most investigated pigments. Natural astaxanthin is mainly produced from microalgae, and it shows much stronger antioxidant properties than its synthetic counterpart. This paper aims to summarize and discuss the important aspects and recent findings associated with the possible use of crustacean byproducts as a source of astaxanthin. In the last five years of research on the crustaceans and their byproducts as a source of natural astaxanthin, there are many new findings regarding the astaxanthin content in different species and new green extraction protocols for its extraction. However, there is a lack of information on the amounts of astaxanthin currently obtained from the byproducts as well as on the cost-effectiveness of the astaxanthin production from the byproducts. Improvement in these areas would most certainly contribute to the reduction of waste and reuse in the crustacean processing industry. Successful exploitation of byproducts for recovery of this valuable compound would have both environmental and social benefits. Finally, astaxanthin's strong biological activity and prominent health benefits have been discussed in the paper.

Keywords: astaxanthin; biological activities; byproducts; crustaceans; health benefits.

Publication types

  • Review

MeSH terms

  • Animals
  • Crustacea*
  • Food-Processing Industry
  • Humans
  • Seafood
  • Waste Products*
  • Xanthophylls / pharmacology
  • Xanthophylls / therapeutic use

Substances

  • Waste Products
  • Xanthophylls
  • astaxanthine